MHRA Lays Out Its Thinking on AI and Medicines Regulation

MHRA lays out its thinking on AI and medicines regulation

An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.

MHRA 2030 strategy vows to reduce regulatory barriers and create modern framework for AI as a medical device – HTN Health Tech News

In its newly published 2030 strategy, the Medicines and Healthcare products Regulatory Agency (MHRA) has vowed to reduce regulatory barriers for UK start-ups and SMEs, develop a modern regulatory framework for AI as a medical device, and move forward with plans for the use of AI in transforming medicines development. […]

MHRA unveils ambitious strategy to accelerate innovation and improve patient outcomes

MHRA launches its 2030 Strategy, outlining plans to accelerate patient access to innovative medicines, harness AI and real-world data, strengthen regulation, and boost UK life sciences.

MHRA 2030 Strategy to modernise patient-centred regulation for the era of AI and personalised medicines

The Medicines and Healthcare products Regulatory Agency (MHRA) has set out ambitious plans to translate cutting-edge scientific and technological innovation into better health outcomes for patients across all four nations of the UK, in its 2030 Strategy published today.

Early Look: MHRA 2030 Strategy - What You Need To Know

Explore the MHRA’s 2030 strategy for patient safety, faster treatment access, AI regulation, innovation and international collaboration.